CEO Dig Howitt highlighted a 6% increase in net sales on a constant currency basis, driven by 13% growth in Cochlear implant revenue and 22% growth in Acoustics revenue. Services revenue declined by ...

Impeccable Cantonese cooking is on show at the Club Rivers restaurant.

Cochlear Limited, a medical device company specializing in implantable hearing solutions, is launching two new bone conduction sound processor devices for patients with high levels of hearing loss.

LONE TREE, Colo., March 3, 2025 /PRNewswire/ — In celebration of World Hearing Day, Cochlear, the global leader in implantable hearing solutions, is proud to announce that it has been named the number ...

Cochlear expects full-year earnings to be at the lower end of guidance, and has written down the value of its investment in Saluda.

LONE TREE, Colo., July 8, 2025 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced the U.S Food and Drug Administration (FDA) approval of ...

Jefferies analyst David Stanton maintained a Hold rating on Cochlear Limited (CHEOF – Research Report) today and set a price target of A$304.00. The company’s shares closed yesterday at $232.96.

In a report released on January 17, David Stanton from Jefferies maintained a Hold rating on Cochlear Limited (CHEOF – Research Report), with a price target of A$305.00. The company’s shares closed ...

The Cochlear Ltd (ASX: COH) share price has struggled to regain momentum after a difficult year. The ASX healthcare stock finished Friday down 0.3% at $263.24. That is above its late-December low, but ...

LONE TREE, Colo., June 2, 2025 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, announces today the commercial release of the new Cochlear™ Baha® 7 ...

Cochlear reaffirmed guidance for FY 2025 underlying net profit between $410 million and $430 million, though it expects to achieve the lower end of this range. The revision is driven by weaker ...